Gammadiagnostics
1 known investors
Gamma Diagnostics develops diagnostics based on Gamma Prime Fibrinogen (GPF), a biomarker used to predict clotting and inflammation in cardiovascular disease and other conditions. The company operates in the medical diagnostics field.
Investors · 1
Frequently asked questions
- What does Gammadiagnostics do?
- Gamma Diagnostics develops diagnostics based on Gamma Prime Fibrinogen (GPF), a biomarker used to predict clotting and inflammation in cardiovascular disease and other conditions. The company operates in the medical diagnostics field.
- Who are Gammadiagnostics's investors?
- Gammadiagnostics's investors include Expert DOJO.